Rhabdomyolysis News and Research

RSS
Rhabdomyolysis (often shortened to simply "rhabdo") is the rapid breakdown (''lysis'') of skeletal muscle (''rhabdomyo'') due to injury to muscle tissue.
Merck announces initial results from ISENTRESS Phase III study in HIV-1

Merck announces initial results from ISENTRESS Phase III study in HIV-1

VYTORIN reduces major vascular events in patients with chronic kidney disease

VYTORIN reduces major vascular events in patients with chronic kidney disease

Colcrys safe for treating gout flares

Colcrys safe for treating gout flares

Positive results from Ardea's RDEA594 combination study with febuxostat or allopurinol for gout

Positive results from Ardea's RDEA594 combination study with febuxostat or allopurinol for gout

Lundbeck, Merck announce commercialization agreement for SYCREST sublingual tablets

Lundbeck, Merck announce commercialization agreement for SYCREST sublingual tablets

IDMC recommends early termination of Phase 3 intramuscular depot aripiprazole trial

IDMC recommends early termination of Phase 3 intramuscular depot aripiprazole trial

Johns Hopkins Children's Center urges new screening program to improve sickle cell trait

Johns Hopkins Children's Center urges new screening program to improve sickle cell trait

European Commission approves MSD's MAA for SYCREST in manic episodes associated with bipolar I disorder

European Commission approves MSD's MAA for SYCREST in manic episodes associated with bipolar I disorder

Lots of water breaks prevent dehydration in kids

Lots of water breaks prevent dehydration in kids

BBD reports analyze effectiveness and safety of statin use

BBD reports analyze effectiveness and safety of statin use

CHMP adopts positive opinion on pending MAA for SYCREST sublingual tablets

CHMP adopts positive opinion on pending MAA for SYCREST sublingual tablets

Experts address fundamental questions related to renal failure in ICU

Experts address fundamental questions related to renal failure in ICU

Optivia Biotechnology launches OptiDDI Suite for assessing transporter-related DDIs

Optivia Biotechnology launches OptiDDI Suite for assessing transporter-related DDIs

High dose of Zocor could lead to muscle injury, warns FDA

High dose of Zocor could lead to muscle injury, warns FDA

Winners of NMSIS scholarship award

Winners of NMSIS scholarship award

Paracetamol reduces damage caused to kidneys following severe muscle injury

Paracetamol reduces damage caused to kidneys following severe muscle injury

Seroquel XR supplemental NDA recommended for approval

Seroquel XR supplemental NDA recommended for approval

FDA approves Symbyax for treatment-resistant depression

FDA approves Symbyax for treatment-resistant depression

Taser study finds serious injuries rare after Taser use

Taser study finds serious injuries rare after Taser use

Lilly receives complete response letter for Olanzapine LAI for treatment of schizophrenia

Lilly receives complete response letter for Olanzapine LAI for treatment of schizophrenia